What is Gas Station Heroin? Understanding the Risks of Tianeptine

Gas station heroin is the street name for tianeptine, an unregulated atypical antidepressant that activates the same mu-opioid receptors as heroin and fentanyl. Tianeptine is not approved by the FDA for any medical use in the United States.

Despite this, products containing tianeptine are widely sold in convenience stores, gas stations, and vape shops under brand names like ZaZa, Tianaa, Neptune’s Fix, and Pegasus. The substance produces opioid-like euphoria at high doses, creating rapid physical dependence and severe withdrawal symptoms.

Understanding what tianeptine actually is, how it hijacks the brain’s opioid system, and why it remains accessible despite FDA warnings can help you or someone you care about avoid a dangerous and fast-developing substance use pattern.

Key Takeaways

• The FDA issued a public safety warning stating that tianeptine is not approved for any medical use in the United States and urged consumers to avoid all products containing the substance due to reports of serious harm, overdose, and death.
• Tianeptine binds to mu-opioid receptors in the brain, producing effects pharmacologically similar to heroin and prescription opioids despite being marketed as a dietary supplement.
• According to the CDC, U.S. poison control centers received over 880 tianeptine-related calls between 2015 and 2021, a dramatic increase from just 27 calls in the preceding decade.
• At least 15 states have classified tianeptine as a controlled substance, though it remains unscheduled at the federal level and available in many other states including North Carolina.
• Commercial tianeptine products frequently contain doses 100 times higher than the therapeutic dose used in countries where the drug is legally prescribed.

What Is Tianeptine?

Tianeptine is an atypical tricyclic antidepressant originally developed in France during the 1960s for the treatment of major depressive disorder.

Origin and Pharmaceutical Classification

Tianeptine is legally prescribed under the brand names Coaxil, Stablon, and Tatinol in parts of Europe, Asia, and South America. In those countries, physicians prescribe therapeutic doses of 12.5 mg taken three times daily, totaling 37.5 mg per day.

The drug is classified as an atypical tricyclic because its pharmacological profile differs fundamentally from other antidepressants in the same structural class. While traditional tricyclics primarily inhibit norepinephrine and serotonin reuptake, tianeptine enhances serotonin reuptake and simultaneously acts as a full agonist at the mu-opioid receptor.

Why It Is Called Gas Station Heroin

The name “gas station heroin” reflects both where tianeptine products are sold and how the substance affects the brain. Unlike illicit street drugs that require a dealer, tianeptine products sit on retail shelves alongside energy drinks and supplements.

The “heroin” component of the nickname refers to tianeptine’s direct activation of mu-opioid receptors. Research published in Translational Psychiatry confirmed that tianeptine functions as a mu-opioid receptor agonist, producing dose-dependent euphoria, sedation, and respiratory depression identical to the pharmacological effects of heroin and morphine.

Brand Names and Product Forms

Tianeptine enters the U.S. market disguised as dietary supplements, nootropics, or “mood enhancers.” Common product names and their typical forms include:

• ZaZa Red and ZaZa Silver: Sold as capsules or tablets in gas stations and convenience stores, often displayed near checkout counters alongside energy supplements.
• Tianaa and Tianna Red: Marketed as “dietary supplements” in capsule form, with packaging that mimics legitimate supplement branding.
• Neptune’s Fix: Sold as a flavored liquid shot in small bottles, sometimes combined with synthetic cannabinoid receptor agonists and other undisclosed substances.
• Pegasus and TD Red: Available as powders or capsules through online retailers and smoke shops, with no standardized dosing or ingredient verification.

How Tianeptine Affects the Brain

Tianeptine produces its dangerous effects through a dual mechanism involving both serotonergic and opioidergic neurotransmitter systems.

Mu-Opioid Receptor Agonism

At therapeutic doses (12.5 mg), tianeptine modulates serotonin reuptake and produces mild antidepressant effects. At the supertherapeutic doses commonly found in gas station products (500 mg to 5,000 mg per serving), tianeptine’s mu-opioid receptor agonism dominates the pharmacological profile.

This receptor binding triggers the same massive dopamine release in the nucleus accumbens that heroin, fentanyl, and oxycodone produce. The resulting euphoria reinforces compulsive redosing, and physical dependence develops within days to weeks of regular use.

Rapid Tolerance and Dose Escalation

Tianeptine’s short duration of action (2 to 4 hours) drives users to redose frequently throughout the day. Tolerance to the opioid effects develops rapidly, compelling users to escalate their daily intake to maintain the same level of euphoria.

Published case reports document individuals consuming between 1,300 mg and 10,000 mg of tianeptine daily. These doses represent 35 to 270 times the standard therapeutic amount, placing extreme pharmacological stress on opioid receptor systems throughout the central nervous system.

Serotonergic and Noradrenergic Activity

Tianeptine’s pharmacology extends beyond simple opioid agonism. The drug also modulates serotonin and norepinephrine signaling, which means tianeptine overdose does not always present as classic opioid toxicity.

Some individuals experiencing tianeptine toxicity develop agitation, hypertension, tachycardia, and seizures alongside respiratory depression. This mixed pharmacological profile complicates emergency treatment because standard opioid overdose protocols may not fully address the non-opioidergic symptoms.

Dangers and Side Effects of Tianeptine

Tianeptine produces a spectrum of adverse effects that mirror and sometimes exceed the severity of traditional opioid misuse.

Common Side Effects

Regular tianeptine use at supertherapeutic doses produces predictable opioid-related side effects. Commonly reported adverse reactions include:

• Drowsiness and cognitive impairment: Mu-opioid receptor activation suppresses cortical arousal systems, producing sedation and impaired concentration that interfere with driving and daily functioning.
• Nausea, vomiting, and constipation: Opioid receptors in the gastrointestinal tract slow intestinal motility, causing severe constipation and persistent nausea identical to the GI effects of prescription opioids.
• Constricted pupils and dry mouth: Miosis (pinpoint pupils) and reduced salivary output signal active opioid receptor engagement and serve as visible indicators of recent tianeptine use.
• Mood instability between doses: The short half-life of tianeptine creates rapid cycling between opioid-mediated euphoria and inter-dose irritability, anxiety, and early withdrawal symptoms.

Severe Side Effects and Overdose Risk

Higher doses and polysubstance combinations involving tianeptine produce life-threatening toxicity. Severe adverse effects that require immediate emergency medical attention include:

• Respiratory depression and respiratory arrest: Tianeptine’s mu-opioid agonism suppresses brainstem respiratory drive at high doses, producing the same potentially fatal respiratory failure as heroin overdose.
• Loss of consciousness and coma: Excessive mu-opioid receptor stimulation produces profound CNS depression that renders the individual unresponsive and unable to protect their airway.
• Seizures and cardiovascular instability: Tianeptine’s serotonergic activity combined with opioid effects can trigger seizure activity and cardiac arrhythmias, especially when co-ingested with alcohol or benzodiazepines.
• Contamination with synthetic cannabinoids: A 2024 CDC investigation of a New Jersey poisoning cluster found Neptune’s Fix products contained both tianeptine and synthetic cannabinoid receptor agonists, producing unpredictable and severe multi-system toxicity.

Long-Term Health Consequences

Sustained tianeptine misuse causes progressive damage to multiple organ systems. Long-term consequences of chronic tianeptine exposure include:

• Severe opioid dependence: Chronic mu-opioid receptor activation produces neuroadaptive changes that generate intense physical dependence, making unsupervised cessation extremely difficult and medically risky.
• Hepatotoxicity: High-dose tianeptine use places significant metabolic burden on the liver, with some clinical reports suggesting elevated liver enzymes and hepatic inflammation in chronic users.
• Cognitive and emotional deterioration: Repeated opioid-serotonin system dysregulation impairs executive function, emotional regulation, and stress response capacity over months of sustained use.
• Financial and social destabilization: Users frequently report spending hundreds of dollars per week on gas station tianeptine products as tolerance escalates, depleting financial resources and eroding personal relationships.

Tianeptine Withdrawal Symptoms

Tianeptine withdrawal produces a combination of opioid withdrawal symptoms and mood-related disturbances that many users describe as more severe than withdrawal from traditional opioids.

Opioid-Like Withdrawal Symptoms

Abrupt cessation of tianeptine triggers classic opioid withdrawal symptoms driven by sudden mu-opioid receptor vacancy. The withdrawal timeline typically follows this progression:

1. Early withdrawal (6 to 12 hours after last dose): Anxiety, muscle aches, rhinorrhea (runny nose), excessive lacrimation (tearing), yawning, and restlessness begin as opioid receptor occupancy drops below the threshold for physiological homeostasis.
2. Peak withdrawal (24 to 72 hours): Severe abdominal cramping, diarrhea, nausea, vomiting, piloerection (goosebumps), insomnia, tachycardia, hypertension, and intense drug cravings dominate this window and drive extremely high relapse rates without medical supervision.
3. Protracted withdrawal (days 4 to 14 and beyond): Persistent dysphoria, anhedonia, fatigue, irritability, and episodic cravings gradually improve but may continue for weeks in individuals with histories of high-dose daily use.

“When patients present with dependence on emerging or lesser-known substances, the challenge is that there is often no established detox protocol to follow. That is where our staffing model at Charlotte Detox makes the difference, a 1:3.2 licensed staff-to-patient ratio, hourly nursing rounds, and 15-minute behavioral health checks in the first 24 hours means our medical team can monitor, adjust, and respond to withdrawal presentations in real time, even when the substance is not one we see every day.”

— Sahil Talwar, PA-C, MBA, Medical Provider at Carolina Center for Recovery

Mixed Withdrawal Presentation

Tianeptine’s dual pharmacology produces withdrawal features not typically seen in standard opioid withdrawal. Serotonergic rebound can intensify depressive symptoms, suicidal ideation, and emotional volatility beyond what opioid receptor vacancy alone would produce.

This mixed presentation makes precipitated withdrawal a particular concern if buprenorphine-based medications are introduced too early in the detoxification process. Medical professionals managing tianeptine withdrawal must account for both the opioidergic and non-opioidergic components of the withdrawal syndrome.

Naloxone Response in Tianeptine Overdose

Naloxone (Narcan) can partially reverse the respiratory depression caused by tianeptine overdose because the drug acts on the same mu-opioid receptors that naloxone blocks. However, the reversal may be incomplete due to tianeptine’s additional serotonergic and noradrenergic effects.

Emergency medical providers encountering suspected tianeptine overdose should administer naloxone while monitoring for residual non-opioid symptoms that require additional supportive care.

Legal Status of Tianeptine in the United States

Tianeptine occupies a regulatory gray area in the United States. The Drug Enforcement Administration (DEA) has not classified tianeptine as a federally controlled substance, creating a patchwork of inconsistent state-level regulations.

States That Have Banned Tianeptine

As of early 2026, at least 15 states have classified tianeptine as a Schedule I or Schedule II controlled substance. States with active bans include Alabama, Michigan, Tennessee, Indiana, Ohio, Kentucky, Mississippi, Florida, Oklahoma, Minnesota, Georgia, Connecticut, Delaware, and others.

North Carolina has not yet classified tianeptine as a controlled substance, which means products containing the drug remain legally available in gas stations, convenience stores, and online retailers throughout the state.

FDA Enforcement Actions

The FDA has issued multiple consumer warnings, sent warning letters to companies distributing tianeptine products, and placed import alerts to detain tianeptine shipments at U.S. borders. Despite these actions, enforcement gaps allow continued retail availability through loopholes in dietary supplement labeling laws.

The FDA explicitly states that tianeptine does not qualify as a dietary supplement, does not hold Generally Recognized as Safe (GRAS) status, and is considered an adulterated drug that is illegal to market or sell.

Treatment for Opioid-Related Substance Use at Carolina Center for Recovery

Carolina Center for Recovery in Charlotte, North Carolina provides comprehensive treatment for individuals struggling with tianeptine dependence and other opioid-related substance use disorders.

Medical Detox Program

The medical detox unit provides 24/7 physician-supervised withdrawal management within 16 private rooms. Medical staff use individualized protocols to manage the unique dual-pharmacology withdrawal syndrome produced by tianeptine, monitoring both opioidergic and serotonergic withdrawal features throughout the detoxification process.

Medication-Assisted Treatment (MAT)

Carolina Center for Recovery offers medication-assisted treatment including buprenorphine-based protocols for individuals with opioid-related dependence. MAT reduces cravings, stabilizes opioid receptor function, and significantly improves retention in ongoing treatment programs.

Residential Treatment Program

The residential treatment program delivers 4 to 5 hours of daily group therapy, individual counseling, CBT, DBT, and holistic modalities including yoga and mindfulness meditation. Clients receive comprehensive psychiatric evaluation and a master treatment plan within the first 24 hours.

Partial Hospitalization and Outpatient Programs

The partial hospitalization program and intensive outpatient program provide structured step-down support as individuals transition from residential care. Carolina Center for Recovery’s admissions team can verify insurance and schedule same-day assessments when capacity allows.

Frequently Asked Questions

What Is Gas Station Heroin Made Of?

Gas station heroin products contain tianeptine, an atypical tricyclic antidepressant that activates mu-opioid receptors. Some products also contain undisclosed adulterants including synthetic cannabinoid receptor agonists, caffeine, and other unregulated compounds. The CDC identified synthetic cannabinoids in Neptune’s Fix products linked to a 2024 poisoning cluster in New Jersey.

Is Gas Station Heroin Legal?

Tianeptine’s legal status varies by state. At least 15 states have banned it as a controlled substance, but the DEA has not federally scheduled tianeptine. In states without specific bans, including North Carolina, tianeptine products remain available for purchase at retail locations. The FDA considers tianeptine an unapproved drug that is illegal to market as a dietary supplement.

Can You Overdose on Tianeptine?

Tianeptine overdose is a documented cause of hospitalization and death. The drug suppresses respiratory drive through mu-opioid receptor activation, and commercial products often contain doses 100 times higher than the therapeutic amount. Naloxone can partially reverse tianeptine-related respiratory depression but may not address all symptoms due to the drug’s additional non-opioid pharmacological activity.

Is Tianeptine Withdrawal Dangerous?

Tianeptine withdrawal produces severe opioid-like symptoms including vomiting, diarrhea, tachycardia, hypertension, and intense cravings. The withdrawal syndrome is complicated by serotonergic rebound, which can intensify depression and suicidal ideation. Medical supervision is strongly recommended because unsupervised cessation carries significant relapse risk and potential for medical complications.

How Long Does Tianeptine Stay in Your System?

Tianeptine has a short half-life of approximately 2.5 to 3 hours, meaning the drug clears from the bloodstream within 12 to 15 hours. However, standard urine drug panels do not routinely test for tianeptine, which means the substance may go undetected even during active use. Specialized laboratory testing is required to confirm tianeptine exposure.

References

1. U.S. Food and Drug Administration. (2024). New “gas station heroin” tianeptine product trend. https://www.fda.gov/consumers/health-fraud-scams/new-gas-station-heroin-tianeptine-product-trend
2. Centers for Disease Control and Prevention. (2024). Tianeptine exposures reported to the National Poison Data System. https://www.cdc.gov
3. Drug Enforcement Administration. (2024). Tianeptine: Emerging drug threat. https://www.dea.gov
4. Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024
5. Gassaway, M. M., et al. (2014). The atypical antidepressant and neurorestorative agent tianeptine is a mu-opioid receptor agonist. Translational Psychiatry, 4, e411.
6. Edinoff, A. N., et al. (2023). Tianeptine, an antidepressant with opioid agonist effects: Pharmacology and abuse potential. Pain and Therapy, 12(5), 1121-1134.
7. American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). American Psychiatric Association Publishing.
8. National Institute on Drug Abuse. (2024). Emerging trends and alerts. https://nida.nih.gov/research-topics/trends-statistics